BioXcel Therapeutics Inc. (BTAI)
NASDAQ: BTAI
· Real-Time Price · USD
1.38
0.06 (4.55%)
At close: Jun 03, 2025, 3:59 PM
1.38
0.36%
After-hours: Jun 03, 2025, 06:31 PM EDT
4.55% (1D)
| Bid | 1.21 |
| Market Cap | 8.33M |
| Revenue (ttm) | 1.85M |
| Net Income (ttm) | -40.06M |
| EPS (ttm) | -11.12 |
| PE Ratio (ttm) | -0.12 |
| Forward PE | -0.11 |
| Analyst | Buy |
| Ask | 1.44 |
| Volume | 221,421 |
| Avg. Volume (20D) | 588,171 |
| Open | 1.32 |
| Previous Close | 1.32 |
| Day's Range | 1.31 - 1.43 |
| 52-Week Range | 1.17 - 27.20 |
| Beta | -0.13 |
About BTAI
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol BTAI
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for BTAI stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
+7.73%
BioXcel Therapeutics shares are trading higher aft...
Unlock content with
Pro Subscription
2 months ago
+22.99%
BioXcel Therapeutics shares are trading higher after the company announced it has reached 33% enrollment in its 200-patient SERENITY At-Home trial.
